Representative Jefferson Shreve (R-Indiana) recently sold shares of The Procter & Gamble Company NYSE: PG. In a filing disclosed on March 09th, the Representative disclosed that they had sold between $50,001 and $100,000 in Procter & Gamble stock on February 24th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.
Representative Jefferson Shreve also recently made the following trade(s):
- Purchased $15,001 - $50,000 in shares of RTX NYSE: RTX on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Royal Gold NASDAQ: RGLD on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of QUALCOMM NASDAQ: QCOM on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 2/24/2025.
- Sold $15,001 - $50,000 in shares of Norfolk Southern NYSE: NSC on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 2/24/2025.
- Purchased $50,001 - $100,000 in shares of AbbVie NYSE: ABBV on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of The Cigna Group NYSE: CI on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Adobe NASDAQ: ADBE on 2/24/2025.
Procter & Gamble Price Performance
Shares of NYSE PG traded down $4.17 during mid-day trading on Wednesday, reaching $168.95. The company's stock had a trading volume of 5,536,706 shares, compared to its average volume of 6,399,524. The stock has a market capitalization of $396.16 billion, a P/E ratio of 26.90, a P/E/G ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 1-year low of $153.52 and a 1-year high of $180.43. The stock has a 50-day moving average of $167.14 and a two-hundred day moving average of $169.84. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02. The firm had revenue of $21.88 billion during the quarter, compared to analysts' expectations of $21.66 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business's revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.84 earnings per share. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th were paid a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 annualized dividend and a yield of 2.38%. Procter & Gamble's dividend payout ratio (DPR) is presently 64.01%.
Insiders Place Their Bets
In related news, insider Marc S. Pritchard sold 90,450 shares of the company's stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the completion of the sale, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary A. Coombe sold 18,000 shares of the business's stock in a transaction dated Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total value of $3,089,880.00. Following the completion of the sale, the chief executive officer now directly owns 22,051 shares of the company's stock, valued at $3,785,274.66. This represents a 44.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 143,450 shares of company stock worth $23,988,008 in the last three months. 0.18% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
PG has been the subject of several recent research reports. DA Davidson reiterated a "buy" rating and issued a $209.00 price objective on shares of Procter & Gamble in a research note on Thursday, January 23rd. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating on the stock in a research note on Thursday, January 16th. Barclays upped their price objective on Procter & Gamble from $155.00 to $159.00 and gave the stock an "equal weight" rating in a research report on Thursday, January 23rd. UBS Group reissued a "buy" rating on shares of Procter & Gamble in a research report on Monday, February 10th. Finally, Stifel Nicolaus increased their price target on shares of Procter & Gamble from $161.00 to $165.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Seven analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and an average target price of $181.47.
Read Our Latest Research Report on Procter & Gamble
Institutional Trading of Procter & Gamble
Several hedge funds and other institutional investors have recently bought and sold shares of PG. Swedbank AB raised its position in Procter & Gamble by 3.9% in the third quarter. Swedbank AB now owns 1,503,647 shares of the company's stock valued at $260,432,000 after purchasing an additional 56,583 shares during the period. Howard Capital Management Group LLC increased its position in shares of Procter & Gamble by 1.0% during the third quarter. Howard Capital Management Group LLC now owns 8,327 shares of the company's stock worth $1,442,000 after acquiring an additional 82 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Procter & Gamble by 14.7% in the third quarter. Principal Financial Group Inc. now owns 4,734,588 shares of the company's stock worth $820,031,000 after acquiring an additional 608,168 shares in the last quarter. Summit Global Investments boosted its holdings in Procter & Gamble by 14.2% in the third quarter. Summit Global Investments now owns 6,706 shares of the company's stock valued at $1,161,000 after purchasing an additional 835 shares during the last quarter. Finally, Hollencrest Capital Management grew its stake in Procter & Gamble by 7.0% during the 3rd quarter. Hollencrest Capital Management now owns 6,541 shares of the company's stock valued at $1,133,000 after purchasing an additional 427 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
About Representative Shreve
Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election.
Email editor@ballotpedia.org to notify us of updates to this biography.
Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive.
Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.
Procter & Gamble Company Profile
(
Get Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report